Dexamethasone Inhibits the Growth of B-Lymphoma Cells by Downregulating DOT1L.
Yuting WangNan ZhangWeilong ShangHuagang PengZhen HuYi YangLi TanLi ZhangFengtian HeXiancai RaoPublished in: Cancer reports (Hoboken, N.J.) (2024)
Overall, our findings indicated that DOT1L may serve as a potential drug target and a promising biomarker of Dex sensitivity when it comes to treating B lymphoma.